BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28535665)

  • 1. L1 Cell Adhesion Molecule Promotes Migration and Invasion via JNK Activation in Extrahepatic Cholangiocarcinoma Cells with Activating
    Kim H; Hwang H; Lee H; Hong HJ
    Mol Cells; 2017 May; 40(5):363-370. PubMed ID: 28535665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L1 cell adhesion molecule is a novel independent poor prognostic factor of extrahepatic cholangiocarcinoma.
    Li S; Jo YS; Lee JH; Min JK; Lee ES; Park T; Kim JM; Hong HJ
    Clin Cancer Res; 2009 Dec; 15(23):7345-51. PubMed ID: 19920102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands.
    Nakagawa H; Suzuki N; Hirata Y; Hikiba Y; Hayakawa Y; Kinoshita H; Ihara S; Uchino K; Nishikawa Y; Ijichi H; Otsuka M; Arita J; Sakamoto Y; Hasegawa K; Kokudo N; Tateishi K; Koike K
    Proc Natl Acad Sci U S A; 2017 May; 114(19):E3806-E3815. PubMed ID: 28439013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines.
    Xu L; Hausmann M; Dietmaier W; Kellermeier S; Pesch T; Stieber-Gunckel M; Lippert E; Klebl F; Rogler G
    BMC Cancer; 2010 Jun; 10():302. PubMed ID: 20565817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.
    Ito T; Yamada S; Tanaka C; Ito S; Murai T; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting c-MET by Tivantinib through synergistic activation of JNK/c-jun pathway in cholangiocarcinoma.
    Wei K; Li M; Zöller M; Wang M; Mehrabi A; Hoffmann K
    Cell Death Dis; 2019 Mar; 10(3):231. PubMed ID: 30850583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer.
    Chen DL; Zeng ZL; Yang J; Ren C; Wang DS; Wu WJ; Xu RH
    J Hematol Oncol; 2013 Jun; 6():43. PubMed ID: 23806079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of L1CAM expression and its biological role in the progression of oral squamous cell carcinoma.
    Kim JH; Lee KW; Ahn DG; Oh KY; Yoon HJ
    Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36825596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant l1 cell adhesion molecule affects tumor behavior and chemosensitivity in anaplastic thyroid carcinoma.
    Kim KS; Min JK; Liang ZL; Lee K; Lee JU; Bae KH; Lee MH; Lee SE; Ryu MJ; Kim SJ; Kim YK; Choi MJ; Jo YS; Kim JM; Shong M
    Clin Cancer Res; 2012 Jun; 18(11):3071-8. PubMed ID: 22472175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L1 cell adhesion molecule induces melanoma cell motility by activation of mitogen-activated protein kinase pathways.
    Yi YS; Baek KS; Cho JY
    Pharmazie; 2014 Jun; 69(6):461-7. PubMed ID: 24974583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways.
    Jiao CY; Feng QC; Li CX; Wang D; Han S; Zhang YD; Jiang WJ; Chang J; Wang X; Li XC
    Cell Death Dis; 2021 Jan; 12(1):63. PubMed ID: 33431813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin promotes invasion and migration of KRAS
    Wang G; Yin L; Peng Y; Gao Y; Gao H; Zhang J; Lv N; Miao Y; Lu Z
    Cell Prolif; 2019 May; 52(3):e12575. PubMed ID: 30838710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation and Stabilization of PIN1 by JNK Promote Intrahepatic Cholangiocarcinoma Growth.
    Lepore A; Choy PM; Lee NCW; Carella MA; Favicchio R; Briones-Orta MA; Glaser SS; Alpini G; D'Santos C; Tooze RM; Lorger M; Syn WK; Papakyriakou A; Giamas G; Bubici C; Papa S
    Hepatology; 2021 Nov; 74(5):2561-2579. PubMed ID: 34048060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
    Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
    Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of L1 cell adhesion molecule correlates with aggressive tumor progression of patients with breast cancer and promotes motility of breast cancer cells.
    Zhang J; Yang F; Ding Y; Zhen L; Han X; Jiao F; Tang J
    Int J Clin Exp Pathol; 2015; 8(8):9240-7. PubMed ID: 26464672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
    Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting l1 cell adhesion molecule using lentivirus-mediated short hairpin RNA interference reverses aggressiveness of oral squamous cell carcinoma.
    Hung SC; Wu IH; Hsue SS; Liao CH; Wang HC; Chuang PH; Sung SY; Hsieh CL
    Mol Pharm; 2010 Dec; 7(6):2312-23. PubMed ID: 21033655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells.
    Hoang VT; Nyswaner K; Torres-Ayuso P; Brognard J
    J Biol Chem; 2020 Jun; 295(25):8470-8479. PubMed ID: 32358059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinoma.
    Cho S; Lee TS; Song IH; Kim AR; Lee YJ; Kim H; Hwang H; Jeong MS; Kang SG; Hong HJ
    PLoS One; 2017; 12(2):e0170078. PubMed ID: 28166242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma.
    Takemura Y; Ojima H; Oshima G; Shinoda M; Hasegawa Y; Kitago M; Yagi H; Abe Y; Hori S; Fujii-Nishimura Y; Kubota N; Masuda Y; Hibi T; Sakamoto M; Kitagawa Y
    Cancer Med; 2021 Aug; 10(16):5599-5613. PubMed ID: 34245137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.